Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",9.846428754761858e-05,5.415064102564102,49.95838849596055,"['MC4R', 'P2RY14', 'HTR2B', 'ACKR4', 'NMBR', 'GPR3', 'SSTR1', 'MCHR1', 'HCRTR2']",0.023237571861237986,0,0,9
2,Peptide GPCRs WP24,0.00028346172516283244,10.103484216795712,82.52963845979292,"['MC4R', 'GNRHR', 'SSTR1', 'NMBR', 'HCRTR2']",0.033448483569214225,0,0,5
3,Vitamin D Receptor Pathway WP2877,0.0005376123491924976,4.735666418466121,35.65186224542383,"['CEACAM1', 'ABCB1', 'CCND1', 'IGFBP5', 'PNOC', 'TIMP2', 'G0S2', 'JUNB']",0.04229217146980982,0,0,8
4,Spinal Cord Injury WP2431,0.0014812397993448218,4.53323754789272,29.53347977603723,"['C1QB', 'EGR1', 'NR4A1', 'BTG2', 'CCND1', 'PDYN', 'ROS1']",0.08739314816134448,0,0,7
5,Hypertrophy Model WP516,0.0029566327636503945,12.600185528756958,73.37975386377472,"['NR4A3', 'MSTN', 'IL18']",0.13955306644429863,0,0,3
6,Drug Induction of Bile Acid Pathway WP2289,0.0064563833414262055,23.033898305084747,116.15271586889082,"['ABCB1', 'SLC10A1']",0.2539510780960974,0,0,2
7,Allograft Rejection WP2328,0.008533284785716048,5.4446898213210195,25.937309406388785,"['C1QB', 'ABCB1', 'HLA-DRA', 'HLA-E']",0.28769360134699823,0,0,4
8,Sleep regulation WP3591,0.01248398076861653,6.9255102040816325,30.356651172912038,"['IL18', 'CRH', 'HCRTR2']",0.28986662152607134,0,0,3
9,Cytokines and Inflammatory Response WP530,0.014852019932167016,13.159322033898306,55.39573733284511,"['IL7', 'HLA-DRA']",0.28986662152607134,0,0,2
10,Prader-Willi and Angelman Syndrome WP3998,0.015337695576479753,4.512777824023974,18.851866343903254,"['GABRR2', 'MAGEL2', 'CCND1', 'TYR']",0.28986662152607134,0,0,4
11,Tryptophan metabolism WP465,0.017487359310784007,6.020851818988465,24.36203414016991,"['HAAO', 'CYP2C18', 'ACMSD']",0.28986662152607134,0,0,3
12,Complement and Coagulation Cascades WP558,0.017487359310784007,6.020851818988465,24.36203414016991,"['C1QB', 'CPB2', 'F5']",0.28986662152607134,0,0,3
13,Oxidation by Cytochrome P450 WP43,0.019368575595018193,5.769557823129252,22.7557322858402,"['CYP26A1', 'CYP2C18', 'CYP3A7']",0.28986662152607134,0,0,3
14,Metapathway biotransformation Phase I and II WP702,0.02029919422998712,2.9611756964246547,11.5402171906459,"['CYP26A1', 'GLYAT', 'GAL3ST2', 'CYP2C18', 'FMO5', 'CYP3A7']",0.28986662152607134,0,0,6
15,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.02138059937984993,inf,inf,['FMO5'],0.28986662152607134,0,0,1
16,Development and heterogeneity of the ILC family WP3893,0.022060935518835062,10.23352165725047,39.03010777228125,"['IL7', 'IL18']",0.28986662152607134,0,0,2
17,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.022060935518835062,10.23352165725047,39.03010777228125,"['CCND1', 'ROS1']",0.28986662152607134,0,0,2
18,Corticotropin-releasing hormone signaling pathway WP2355,0.022108471133344423,3.308219178082192,12.610251451786567,"['NR4A1', 'IL18', 'CRH', 'FOSB', 'JUNB']",0.28986662152607134,0,0,5
19,Genes targeted by miRNAs in adipocytes WP1992,0.026104230596475965,9.20949152542373,33.574655405434406,"['KCNE1', 'KCNQ1']",0.3080299210384164,0,0,2
20,IL1 and megakaryocytes in obesity WP2865,0.026104230596475965,9.20949152542373,33.574655405434406,"['IL18', 'TIMP2']",0.3080299210384164,0,0,2
21,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.03554099674423096,4.464450296247532,14.898176055852467,"['MSTN', 'IGFBP5', 'TNFSF9']",0.37618466650560556,0,0,3
22,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.03554099674423096,4.464450296247532,14.898176055852467,"['IFITM3', 'IFITM2', 'JUNB']",0.37618466650560556,0,0,3
23,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.03691116446919935,2.5508370377376335,8.415826683971247,"['EGR1', 'SST', 'KCNQ1', 'PAH', 'SSTR1', 'TAC1']",0.37618466650560556,0,0,6
24,Breast cancer pathway WP4262,0.03825606778023107,2.527460168697282,8.248247713849615,"['SHC4', 'SFRP4', 'SHC3', 'CCND1', 'FGF1', 'GADD45G']",0.37618466650560556,0,0,6
25,COVID-19 adverse outcome pathway WP4891,0.04230565630234429,45.9222972972973,145.24462543680292,['IL7'],0.3783004058098544,0,0,1
26,Proximal tubule transport WP4917,0.044059068102712685,4.069627851140456,12.706290107953935,"['SLC22A6', 'ABCB1', 'SLC3A1']",0.3783004058098544,0,0,3
27,Kynurenine Pathway and links to Cellular Senescence WP5044,0.044883098994389505,6.576271186440678,20.41073322298456,"['HAAO', 'ACMSD']",0.3783004058098544,0,0,2
28,Pregnane X receptor pathway WP2876,0.044883098994389505,6.576271186440678,20.41073322298456,"['ABCB1', 'CYP3A7']",0.3783004058098544,0,0,2
29,Imatinib and Chronic Myeloid Leukemia WP3640,0.05016516756086147,6.137401129943503,18.36577006172058,"['SPRED2', 'ABCB1']",0.3946326514787769,0,0,2
30,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.05016516756086147,6.137401129943503,18.36577006172058,"['CYP26A1', 'ABCB1']",0.3946326514787769,0,0,2
31,Gastric acid production WP2596,0.0627847810547779,22.95945945945946,63.55276127746921,['MUC6'],0.463037760278987,0,0,1
32,let-7 inhibition of ES cell reprogramming WP3299,0.0627847810547779,22.95945945945946,63.55276127746921,['EGR1'],0.463037760278987,0,0,1
33,Unfolded protein response WP4925,0.07328974315313157,4.843889384478144,12.658703773427472,"['PPP1R15A', 'XBP1']",0.508717040709972,0,0,2
34,IL-7 signaling pathway WP205,0.07328974315313157,4.843889384478144,12.658703773427472,"['CCND1', 'IL7']",0.508717040709972,0,0,2
35,Nuclear Receptors Meta-Pathway WP2882,0.07688417484197972,1.8632957173410305,4.780201710367548,"['EGR1', 'ABCB1', 'CCND1', 'SLC10A1', 'B3GNT5', 'SPINK13', 'JUNB', 'CYP3A7']",0.5184190075059204,0,0,8
36,Codeine and Morphine Metabolism WP1604,0.0828274355964788,15.30518018018018,38.12514145548901,['ABCB1'],0.5285808098017846,0,0,1
37,Phosphodiesterases in neuronal function WP4222,0.08287072018078825,3.0723356009070293,7.65157031627208,"['ADCY10', 'PDE6C', 'PDE5A']",0.5285808098017846,0,0,3
38,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.0859000137513198,4.381920903954803,10.755737245489591,"['CCND1', 'FGF1']",0.5334842959292493,0,0,2
39,Photodynamic therapy-induced unfolded protein response WP3613,0.09243223228284995,4.1824345146379045,9.959545682445347,"['PPP1R15A', 'XBP1']",0.5567397912321903,0,0,2
40,Insulin Signaling WP481,0.0956957693971122,1.9672442787160926,4.6162984174760435,"['MAP4K1', 'EGR1', 'XBP1', 'PRKCH', 'SHC3', 'RRAD']",0.5567397912321903,0,0,6
41,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.10244288803162166,11.47804054054054,26.15213946813504,['CYP2C18'],0.5567397912321903,0,0,1
42,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.10244288803162166,11.47804054054054,26.15213946813504,['ABCB1'],0.5567397912321903,0,0,1
43,Circadian rhythm related genes WP3594,0.10532485637212267,1.91240668325631,4.304264880480435,"['PER2', 'EGR1', 'MAGEL2', 'EGR3', 'CRH', 'HCRTR2']",0.5567397912321903,0,0,6
44,Pre-implantation embryo WP3527,0.1059048028356751,3.8333333333333335,8.60665625358102,"['EGR1', 'FOSB']",0.5567397912321903,0,0,2
45,DNA damage response WP707,0.1085170779520371,2.70968387354942,6.01779524682481,"['CCND1', 'CYCS', 'GADD45G']",0.5567397912321903,0,0,3
46,Oncostatin M Signaling Pathway WP2374,0.1085170779520371,2.70968387354942,6.01779524682481,"['EGR1', 'PRKCH', 'JUNB']",0.5567397912321903,0,0,3
47,miRNA regulation of DNA damage response WP1530,0.11767335055678192,2.6070465922217942,5.57866964168911,"['CCND1', 'CYCS', 'GADD45G']",0.5697715182328769,0,0,3
48,Differentiation Pathway WP2848,0.11986390404846566,3.5379400260756193,7.505380001909717,"['FST', 'FGF1']",0.5697715182328769,0,0,2
49,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.11986390404846566,3.5379400260756193,7.505380001909717,"['IL18', 'NLRC4']",0.5697715182328769,0,0,2
50,Biogenic Amine Synthesis WP550,0.12164021214561416,9.181756756756757,19.343093767952627,['PAH'],0.5697715182328769,0,0,1
51,Male infertility WP4673,0.12312859080456236,2.1696848022485447,4.544461264873262,"['ABCB1', 'HLA-DRA', 'TEX15', 'ETV5']",0.5697715182328769,0,0,4
52,NAD Biosynthesis II (from tryptophan) WP2485,0.14042829044295088,7.650900900900901,15.019164583373872,['HAAO'],0.6144349667086997,0,0,1
53,Vitamin A and carotenoid metabolism WP716,0.14157401594815286,3.1712448860315603,6.19957006658327,"['CYP26A1', 'RBP2']",0.6144349667086997,0,0,2
54,Endometrial cancer WP4155,0.1417390048839167,2.3814215341308937,4.652744964850106,"['CCND1', 'FGF1', 'GADD45G']",0.6144349667086997,0,0,3
55,Development of ureteric collection system WP5053,0.14898654497958508,3.0653107344632766,5.836042898066669,"['CCND1', 'ETV4']",0.6144349667086997,0,0,2
56,Oxidative Damage WP3941,0.15647531678515533,2.9662110442864953,5.501897323907063,"['C1QB', 'CYCS']",0.6144349667086997,0,0,2
57,Bile acids synthesis and enterohepatic circulation  WP4389,0.1588158176662317,6.5574324324324325,12.065742087119355,['SLC10A1'],0.6144349667086997,0,0,1
58,Blood Clotting Cascade WP272,0.1588158176662317,6.5574324324324325,12.065742087119355,['F5'],0.6144349667086997,0,0,1
59,Leptin and adiponectin WP3934,0.1588158176662317,6.5574324324324325,12.065742087119355,['LEPR'],0.6144349667086997,0,0,1
60,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.1588158176662317,6.5574324324324325,12.065742087119355,['CCND1'],0.6144349667086997,0,0,1
61,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1588158176662317,6.5574324324324325,12.065742087119355,['HLA-DRA'],0.6144349667086997,0,0,1
62,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.17253802492205242,2.157206632653061,3.790508955253027,"['CCND1', 'CYCS', 'GADD45G']",0.6412554503483734,0,0,3
63,Farnesoid X receptor pathway WP2879,0.17681130474724943,5.737331081081081,9.940914008694074,['SLC10A1'],0.6412554503483734,0,0,1
64,Purine metabolism WP4792,0.17681130474724943,5.737331081081081,9.940914008694074,['PRPS1'],0.6412554503483734,0,0,1
65,Hedgehog Signaling Pathway WP4249,0.17933415136861292,2.703888334995015,4.6466441250787245,"['EVC', 'CCND1']",0.6412554503483734,0,0,2
66,NO/cGMP/PKG mediated Neuroprotection WP4008,0.17933415136861292,2.703888334995015,4.6466441250787245,"['CNGB3', 'CYCS']",0.6412554503483734,0,0,2
67,Non-small cell lung cancer WP4255,0.19402924542032932,2.0297118847539015,3.3282127189005517,"['CCND1', 'CYCS', 'GADD45G']",0.6497606187238406,0,0,3
68,Complement Activation WP545,0.19442308242916378,5.099474474474475,8.351504488909477,['C1QB'],0.6497606187238406,0,0,1
69,Dopamine metabolism WP2436,0.19442308242916378,5.099474474474475,8.351504488909477,['TYR'],0.6497606187238406,0,0,1
70,Chemokine signaling pathway WP3929,0.20926366493326287,1.737136969540859,2.7171606267947945,"['SHC4', 'SHC3', 'DOCK2', 'CXCL14']",0.6497606187238406,0,0,4
71,Serotonin and anxiety-related events WP3944,0.21165930510911135,4.589189189189189,7.125989020377795,['CRH'],0.6497606187238406,0,0,1
72,Leptin Insulin Overlap WP3935,0.21165930510911135,4.589189189189189,7.125989020377795,['LEPR'],0.6497606187238406,0,0,1
73,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.21165930510911135,4.589189189189189,7.125989020377795,['CCND1'],0.6497606187238406,0,0,1
74,"NAD metabolism, sirtuins and aging WP3630",0.21165930510911135,4.589189189189189,7.125989020377795,['ROS1'],0.6497606187238406,0,0,1
75,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.22629145593842862,2.29728813559322,3.413612765096956,"['CCND1', 'JUNB']",0.6497606187238406,0,0,2
76,TGF-beta Signaling Pathway WP366,0.22731806740427174,1.6734719205708968,2.479089778000874,"['MAP4K1', 'CCND1', 'FOSB', 'JUNB']",0.6497606187238406,0,0,4
77,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.22852795456764596,4.171683046683047,6.1578077316145805,['SST'],0.6497606187238406,0,0,1
78,Dopaminergic Neurogenesis WP2855,0.22852795456764596,4.171683046683047,6.1578077316145805,['SLC18A2'],0.6497606187238406,0,0,1
79,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.22852795456764596,4.171683046683047,6.1578077316145805,['SFRP4'],0.6497606187238406,0,0,1
80,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.23421704208846245,2.241091360066143,3.2529599384624306,"['PPP1R15A', 'XBP1']",0.6497606187238406,0,0,2
81,Hepatitis B infection WP4666,0.23649074369396408,1.6433447098976108,2.3694503425617537,"['EGR3', 'ATP6AP1', 'SLC10A1', 'CYCS']",0.6497606187238406,0,0,4
82,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.2387409944668772,1.814983888292159,2.5997393979913817,"['SHC4', 'SHC3', 'CCND1']",0.6497606187238406,0,0,3
83,Tryptophan catabolism leading to NAD+ production WP4210,0.24503684350178737,3.8237612612612613,5.377534024111411,['HAAO'],0.6497606187238406,0,0,1
84,Cori Cycle WP1946,0.24503684350178737,3.8237612612612613,5.377534024111411,['PGAM1'],0.6497606187238406,0,0,1
85,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.24503684350178737,3.8237612612612613,5.377534024111411,['CCND1'],0.6497606187238406,0,0,1
86,Major receptors targeted by epinephrine and norepinephrine WP4589,0.24503684350178737,3.8237612612612613,5.377534024111411,['ADCY10'],0.6497606187238406,0,0,1
87,Matrix Metalloproteinases WP129,0.24503684350178737,3.8237612612612613,5.377534024111411,['TIMP2'],0.6497606187238406,0,0,1
88,miRNAs involved in DNA damage response WP1545,0.24503684350178737,3.8237612612612613,5.377534024111411,['CCND1'],0.6497606187238406,0,0,1
89,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.24503684350178737,3.8237612612612613,5.377534024111411,['HLA-DRA'],0.6497606187238406,0,0,1
90,Exercise-induced Circadian Regulation WP410,0.2580719265821521,2.0878274268104775,2.8279976335122115,"['PER2', 'G0S2']",0.6504057819737193,0,0,2
91,Serotonin and anxiety WP3947,0.2611936191105129,3.5293659043659042,4.738150118721713,['CRH'],0.6504057819737193,0,0,1
92,Mammalian disorder of sexual development WP4842,0.2611936191105129,3.5293659043659042,4.738150118721713,['FST'],0.6504057819737193,0,0,1
93,Synaptic Vesicle Pathway WP2267,0.2739995959753767,1.9967575534266766,2.585059530054512,"['SLC32A1', 'SLC18A2']",0.6504057819737193,0,0,2
94,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.2739995959753767,1.9967575534266766,2.585059530054512,"['MSTN', 'JUNB']",0.6504057819737193,0,0,2
95,Glucocorticoid Receptor Pathway WP2880,0.2739995959753767,1.9967575534266766,2.585059530054512,"['B3GNT5', 'SPINK13']",0.6504057819737193,0,0,2
96,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.27700576664054205,3.277027027027027,4.2067751559802495,['HPGD'],0.6504057819737193,0,0,1
97,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.27700576664054205,3.277027027027027,4.2067751559802495,['GADD45G'],0.6504057819737193,0,0,1
98,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.27700576664054205,3.277027027027027,4.2067751559802495,['CCND1'],0.6504057819737193,0,0,1
99,PPAR-alpha pathway WP2878,0.27700576664054205,3.277027027027027,4.2067751559802495,['CCND1'],0.6504057819737193,0,0,1
100,Myometrial relaxation and contraction pathways WP289,0.2787309055989113,1.5200970298705327,1.9419368136247581,"['RGS4', 'PRKCH', 'IGFBP5', 'CRH']",0.6504057819737193,0,0,4
101,ErbB signaling pathway WP673,0.2791365725541864,1.6610523727563316,2.1195927064629645,"['SHC4', 'SHC3', 'CCND1']",0.6504057819737193,0,0,3
102,Small cell lung cancer WP4658,0.28496723367325427,1.6411564625850341,2.060276764063528,"['CCND1', 'CYCS', 'GADD45G']",0.6504057819737193,0,0,3
103,Osteoblast differentiation WP4787,0.28496723367325427,1.6411564625850341,2.060276764063528,"['PRKCH', 'WNT8A', 'FGF1']",0.6504057819737193,0,0,3
104,VEGFA-VEGFR2 Signaling Pathway WP3888,0.28794857002112284,1.2557795099165472,1.5634120749452303,"['DUSP5', 'NR4A1', 'EGR1', 'NR4A3', 'EGR3', 'CCND1', 'MMRN2', 'CYCS', 'BMX', 'APOLD1']",0.6504057819737193,0,0,10
105,"GPCRs, Class B Secretin-like WP334",0.2924806127156869,3.058333333333333,3.759783173052008,['CALCR'],0.6504057819737193,0,0,1
106,Apoptosis Modulation by HSP70 WP384,0.30762532880366134,2.8669763513513513,3.379800156241391,['CYCS'],0.6504057819737193,0,0,1
107,Constitutive Androstane Receptor Pathway WP2875,0.30762532880366134,2.8669763513513513,3.379800156241391,['ABCB1'],0.6504057819737193,0,0,1
108,Nanomaterial induced apoptosis WP2507,0.30762532880366134,2.8669763513513513,3.379800156241391,['CYCS'],0.6504057819737193,0,0,1
109,Nicotine Activity on Dopaminergic Neurons WP1602,0.30762532880366134,2.8669763513513513,3.379800156241391,['SLC18A2'],0.6504057819737193,0,0,1
110,Nucleotide metabolism WP404,0.30762532880366134,2.8669763513513513,3.379800156241391,['PRPS1'],0.6504057819737193,0,0,1
111,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.30762532880366134,2.8669763513513513,3.379800156241391,['BCL2L14'],0.6504057819737193,0,0,1
112,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.32204754422072623,1.4139144132318193,1.6020443387407717,"['SHC4', 'EGR1', 'LINGO1', 'SHC3']",0.6504057819737193,0,0,4
113,Vitamin D in inflammatory diseases WP4482,0.32244693428358123,2.6981319554848966,3.0537908091038424,['DUSP1'],0.6504057819737193,0,0,1
114,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.32244693428358123,2.6981319554848966,3.0537908091038424,['HPGD'],0.6504057819737193,0,0,1
115,Hippo-Yap signaling pathway WP4537,0.32244693428358123,2.6981319554848966,3.0537908091038424,['MAP4K1'],0.6504057819737193,0,0,1
116,Purine metabolism and related disorders WP4224,0.32244693428358123,2.6981319554848966,3.0537908091038424,['PRPS1'],0.6504057819737193,0,0,1
117,Purinergic signaling WP4900,0.32244693428358123,2.6981319554848966,3.0537908091038424,['P2RY14'],0.6504057819737193,0,0,1
118,AGE/RAGE pathway WP2324,0.32945307094508114,1.7321394307643108,1.9232314088843814,"['MSR1', 'CYCS']",0.6518093670072161,0,0,2
119,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3369522998935609,2.548048048048048,2.7718020896064974,['HTR2B'],0.6518093670072161,0,0,1
120,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.3369522998935609,2.548048048048048,2.7718020896064974,['EGR1'],0.6518093670072161,0,0,1
121,NAD+ biosynthetic pathways WP3645,0.3369522998935609,2.548048048048048,2.7718020896064974,['ACMSD'],0.6518093670072161,0,0,1
122,Ovarian infertility WP34,0.3369522998935609,2.548048048048048,2.7718020896064974,['EGR1'],0.6518093670072161,0,0,1
123,Acute viral myocarditis WP4298,0.3451127784241691,1.6689060092449923,1.7755224364306157,"['CCND1', 'CYCS']",0.6621676073829585,0,0,2
124,Adipogenesis WP236,0.3494423598279793,1.4499462943071966,1.524497679380943,"['SFRP4', 'CYP26A1', 'EBF1']",0.6650677170919606,0,0,3
125,Gastrin signaling pathway WP4659,0.3552977768462933,1.434736394557823,1.4846638338301,"['EGR1', 'PRKCH', 'CCND1']",0.6668541022704443,0,0,3
126,Angiogenesis WP1539,0.3650410693615655,2.2929054054054054,2.3106649045810776,['TIMP2'],0.6668541022704443,0,0,1
127,Vitamin B12 metabolism WP1533,0.3650410693615655,2.2929054054054054,2.3106649045810776,['SERPINA3'],0.6668541022704443,0,0,1
128,Gastric Cancer Network 1 WP2361,0.3650410693615655,2.2929054054054054,2.3106649045810776,['GATD3A'],0.6668541022704443,0,0,1
129,Microglia Pathogen Phagocytosis Pathway WP3937,0.3650410693615655,2.2929054054054054,2.3106649045810776,['C1QB'],0.6668541022704443,0,0,1
130,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.37605379805666006,1.5553002010916404,1.521119471049852,"['SFRP4', 'CCND1']",0.6668541022704443,0,0,2
131,1q21.1 copy number variation syndrome WP4905,0.3786374987467777,2.1835585585585586,2.1206196651237836,['FMO5'],0.6668541022704443,0,0,1
132,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.3786374987467777,2.1835585585585586,2.1206196651237836,['CCND1'],0.6668541022704443,0,0,1
133,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.3786374987467777,2.1835585585585586,2.1206196651237836,['CCND1'],0.6668541022704443,0,0,1
134,MTHFR deficiency WP4288,0.3786374987467777,2.1835585585585586,2.1206196651237836,['CYCS'],0.6668541022704443,0,0,1
135,Melanoma WP4685,0.391301155773743,1.504084467907752,1.4112490596866551,"['CCND1', 'GADD45G']",0.6801376759175166,0,0,2
136,16p11.2 distal deletion syndrome WP4950,0.39194374544399263,2.0841523341523343,1.952094098121886,['PLN'],0.6801376759175166,0,0,1
137,Monoamine GPCRs WP58,0.40496598208009243,1.9933901292596945,1.8019294132693862,['HTR2B'],0.6925505200789986,0,0,1
138,Oxidative Stress WP408,0.40496598208009243,1.9933901292596945,1.8019294132693862,['JUNB'],0.6925505200789986,0,0,1
139,Endoderm differentiation WP2853,0.4132960567716802,1.2984212552945706,1.147273463083992,"['DUSP4', 'DUSP5', 'WNT8A']",0.6942226700315858,0,0,3
140,MECP2 and Associated Rett Syndrome WP3584,0.41385182842787416,1.4332627118644068,1.264492116981499,"['GABRR2', 'SST']",0.6942226700315858,0,0,2
141,Aryl Hydrocarbon Receptor Pathway WP2873,0.41771025061222533,1.9101914414414414,1.667534602409508,['JUNB'],0.6942226700315858,0,0,1
142,Hematopoietic Stem Cell Differentiation WP2849,0.41771025061222533,1.9101914414414414,1.667534602409508,['FOSB'],0.6942226700315858,0,0,1
143,White fat cell differentiation WP4149,0.43018246483658973,1.8336486486486487,1.546766659280191,['EBF1'],0.6999415917521762,0,0,1
144,Endothelin Pathways WP2197,0.43018246483658973,1.8336486486486487,1.546766659280191,['ADCY10'],0.6999415917521762,0,0,1
145,Genes controlling nephrogenesis WP4823,0.43018246483658973,1.8336486486486487,1.546766659280191,['ETV4'],0.6999415917521762,0,0,1
146,Leptin signaling pathway WP2034,0.43598056774394023,1.3687832026309132,1.1363057866578092,"['CCND1', 'LEPR']",0.6999415917521762,0,0,2
147,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.43598056774394023,1.3687832026309132,1.1363057866578092,"['SFRP4', 'CCND1']",0.6999415917521762,0,0,2
148,The influence of laminopathies on Wnt signaling WP4844,0.4543337610987367,1.6975725725725725,1.3392543767322218,['CCND1'],0.7050107486284004,0,0,1
149,TYROBP causal network in microglia WP3945,0.4543337610987367,1.6975725725725725,1.3392543767322218,['IL18'],0.7050107486284004,0,0,1
150,GABA receptor Signaling WP4159,0.4543337610987367,1.6975725725725725,1.3392543767322218,['SLC32A1'],0.7050107486284004,0,0,1
151,MAPK Signaling Pathway WP382,0.45522282370642336,1.135223111352231,0.8933845537855112,"['MAP4K1', 'DUSP4', 'NR4A1', 'DUSP1', 'FGF1']",0.7050107486284004,0,0,5
152,Glycolysis and Gluconeogenesis WP534,0.46602405417809517,1.6368243243243243,1.24974487993166,['PGAM1'],0.7050107486284004,0,0,1
153,Lung fibrosis WP3624,0.46602405417809517,1.6368243243243243,1.24974487993166,['FGF1'],0.7050107486284004,0,0,1
154,Melatonin metabolism and effects WP3298,0.46602405417809517,1.6368243243243243,1.24974487993166,['PER2'],0.7050107486284004,0,0,1
155,Nuclear receptors WP170,0.46602405417809517,1.6368243243243243,1.24974487993166,['NR4A1'],0.7050107486284004,0,0,1
156,Prion disease pathway WP3995,0.46602405417809517,1.6368243243243243,1.24974487993166,['EBF1'],0.7050107486284004,0,0,1
157,Folate Metabolism WP176,0.4774647203205338,1.5802656104380242,1.168235065881553,['SERPINA3'],0.7086897735575218,0,0,1
158,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4774647203205338,1.5802656104380242,1.168235065881553,['PRKCH'],0.7086897735575218,0,0,1
159,miRNA regulation of prostate cancer signaling pathways WP3981,0.4774647203205338,1.5802656104380242,1.168235065881553,['CCND1'],0.7086897735575218,0,0,1
160,Glioblastoma signaling pathways WP2261,0.49267343173247086,1.2220564971751413,0.8651044686582078,"['PRKCH', 'CCND1']",0.7137478016215381,0,0,2
161,Prostaglandin Synthesis and Regulation WP98,0.4996183099714309,1.4780950305143854,1.025666182168152,['HPGD'],0.7137478016215381,0,0,1
162,Senescence and Autophagy in Cancer WP615,0.5062787173020146,1.1901386748844376,0.8100892361435517,"['IGFBP5', 'CXCL14']",0.7137478016215381,0,0,2
163,Calcium Regulation in the Cardiac Cell WP536,0.5074980542944446,1.1175543388086941,0.7579950901792154,"['RGS4', 'PRKCH', 'PLN']",0.7137478016215381,0,0,3
164,Parkinson's disease pathway WP2371,0.5103415232512469,1.4317989864864864,0.9631355607030747,['CYCS'],0.7137478016215381,0,0,1
165,Wnt signaling pathway and pluripotency WP399,0.512992139399322,1.174793568013907,0.7841685468977551,"['PRKCH', 'CCND1']",0.7137478016215381,0,0,2
166,Nonalcoholic fatty liver disease WP4396,0.5180747970738719,1.0995102040816327,0.7230771091185997,"['XBP1', 'LEPR', 'CYCS']",0.7137478016215381,0,0,3
167,Pathways Regulating Hippo Signaling WP4540,0.519645329004782,1.1598369448616177,0.7592394239548352,"['PRKCH', 'PRKD3']",0.7137478016215381,0,0,2
168,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5208356938603886,1.3883087633087634,0.9056224802106178,['MAP4K1'],0.7137478016215381,0,0,1
169,Bladder cancer WP2828,0.5208356938603886,1.3883087633087634,0.9056224802106178,['CCND1'],0.7137478016215381,0,0,1
170,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5208356938603886,1.3883087633087634,0.9056224802106178,['CYCS'],0.7137478016215381,0,0,1
171,IL-5 signaling pathway WP127,0.5208356938603886,1.3883087633087634,0.9056224802106178,['SPRED1'],0.7137478016215381,0,0,1
172,Androgen receptor signaling pathway WP138,0.5262377859413035,1.1452542372881356,0.7352556298022872,"['CCND1', 'ETV5']",0.7137478016215381,0,0,2
173,G Protein Signaling Pathways WP35,0.5262377859413035,1.1452542372881356,0.7352556298022872,"['PRKCH', 'PRKD3']",0.7137478016215381,0,0,2
174,Pancreatic adenocarcinoma pathway WP4263,0.5262377859413035,1.1452542372881356,0.7352556298022872,"['CCND1', 'GADD45G']",0.7137478016215381,0,0,2
175,Integrin-mediated Cell Adhesion WP185,0.5327690585885796,1.1310315965683198,0.7121735377264137,"['SHC3', 'MYPN']",0.7184771304394559,0,0,2
176,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5411563077481468,1.3087837837837837,0.8036549106709557,['CCND1'],0.724320260755313,0,0,1
177,Copper homeostasis WP3286,0.5509921949893256,1.272334834834835,0.758355629009855,['CCND1'],0.724320260755313,0,0,1
178,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5509921949893256,1.272334834834835,0.758355629009855,['MAP4K1'],0.724320260755313,0,0,1
179,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5509921949893256,1.272334834834835,0.758355629009855,['CXCL17'],0.724320260755313,0,0,1
180,IL-18 signaling pathway WP4754,0.5524476565082895,1.0231281102827616,0.6071207311915441,"['NR4A1', 'BTG2', 'IL18', 'CYCS']",0.724320260755313,0,0,4
181,IL-6 signaling pathway WP364,0.5606179316540999,1.2378560993425858,0.7163667023654796,['JUNB'],0.730971446797611,0,0,1
182,Wnt signaling WP428,0.5644950346447719,1.0648797792668505,0.608923486335665,"['SFRP4', 'CCND1']",0.7311356867209386,0,0,2
183,TGF-beta Receptor Signaling WP560,0.570037993036664,1.2051920341394025,0.6773809136622839,['FST'],0.7311356867209386,0,0,1
184,Metabolic reprogramming in colon cancer WP4290,0.570037993036664,1.2051920341394025,0.6773809136622839,['PGAM1'],0.7311356867209386,0,0,1
185,Regulation of Microtubule Cytoskeleton WP2038,0.5792567591836081,1.1742030492030493,0.6411259574246934,['SPRED1'],0.7389437576612514,0,0,1
186,Complement system WP2806,0.5882785173630993,1.1447635135135135,0.6073597474753757,['C4BPA'],0.7424263641587777,0,0,1
187,"GPCRs, Other WP117",0.5882785173630993,1.1447635135135135,0.6073597474753757,['GNRHR'],0.7424263641587777,0,0,1
188,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6057477055020105,1.09009009009009,0.5464531222147048,['FST'],0.7563833782988068,0,0,1
189,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6057477055020105,1.09009009009009,0.5464531222147048,['ADCY10'],0.7563833782988068,0,0,1
190,Cytosolic DNA-sensing pathway WP4655,0.6142032625001174,1.0646605908233815,0.5189468295522804,['IL18'],0.7589108374347,0,0,1
191,RANKL/RANK signaling pathway WP2018,0.6142032625001174,1.0646605908233815,0.5189468295522804,['CALCR'],0.7589108374347,0,0,1
192,Cell cycle WP179,0.6232180242214749,0.9532485875706215,0.4507520430786018,"['CCND1', 'GADD45G']",0.7620697083744459,0,0,2
193,Ebola Virus Pathway on Host WP4217,0.6232180242214749,0.9532485875706215,0.4507520430786018,"['HLA-DRA', 'HLA-E']",0.7620697083744459,0,0,2
194,Modulators of TCR signaling and T cell activation WP5072,0.6305759769450278,1.0171921921921923,0.46904931980375,['MAP4K1'],0.7659015520819145,0,0,1
195,Wnt Signaling Pathway WP363,0.6385007546592706,0.995005875440658,0.44639189539023927,['CCND1'],0.7659015520819145,0,0,1
196,Genotoxicity pathway WP4286,0.6385007546592706,0.995005875440658,0.44639189539023927,['BTG2'],0.7659015520819145,0,0,1
197,Genes related to primary cilium development (based on CRISPR) WP4536,0.6396015749390147,0.9241568224619072,0.4130147736358901,"['TMEM17', 'EVC']",0.7659015520819145,0,0,2
198,Cardiac Hypertrophic Response WP2795,0.6538455988940349,0.9534065315315315,0.40508722146888576,['MAP4K1'],0.7659015520819145,0,0,1
199,Ciliopathies WP4803,0.6604497923533081,0.8847267939433838,0.3670149074665995,"['TMEM17', 'EVC', 'AK7']",0.7659015520819145,0,0,3
200,Selenium Micronutrient Network WP15,0.6612728103943294,0.9338803088803089,0.3862424367922735,['SERPINA3'],0.7659015520819145,0,0,1
201,Kit receptor signaling pathway WP304,0.6612728103943294,0.9338803088803089,0.3862424367922735,['JUNB'],0.7659015520819145,0,0,1
202,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6612728103943294,0.9338803088803089,0.3862424367922735,['PRKCH'],0.7659015520819145,0,0,1
203,p53 transcriptional gene network WP4963,0.6612728103943294,0.9338803088803089,0.3862424367922735,['BTG2'],0.7659015520819145,0,0,1
204,G1 to S cell cycle control WP45,0.6685411852918406,0.9151351351351351,0.3684858205239018,['CCND1'],0.7659015520819145,0,0,1
205,Notch Signaling Pathway Netpath WP61,0.6685411852918406,0.9151351351351351,0.3684858205239018,['CCND1'],0.7659015520819145,0,0,1
206,Oxidative phosphorylation WP623,0.6685411852918406,0.9151351351351351,0.3684858205239018,['ATP6AP1'],0.7659015520819145,0,0,1
207,Focal Adhesion WP306,0.6809879781222159,0.8567602040816327,0.3291763745646677,"['SHC4', 'SHC3', 'CCND1']",0.7763920909992413,0,0,3
208,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7041695745814207,0.8161016949152542,0.28623630841281394,"['CLDN20', 'WNT8A']",0.796219362591883,0,0,2
209,Proteasome Degradation WP183,0.7090005093768678,0.816722972972973,0.2808702414560498,['HLA-E'],0.796219362591883,0,0,1
210,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.713203041198883,0.8016651798988997,0.2709541157772219,"['MAP4K1', 'SHC3']",0.796219362591883,0,0,2
211,AMP-activated protein kinase (AMPK) signaling WP1403,0.7152479019893186,0.802335229966809,0.2688834607144253,['LEPR'],0.796219362591883,0,0,1
212,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7152479019893186,0.802335229966809,0.2688834607144253,['ANGPTL1'],0.796219362591883,0,0,1
213,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7331993280565736,0.7620495495495495,0.23649268884846156,['EGR1'],0.8123710864852177,0,0,1
214,PI3K-Akt signaling pathway WP4172,0.7438186996306437,0.7897404074878478,0.23372995766847832,"['CCND1', 'IL7', 'COL6A6', 'FGF1']",0.8134742418552212,0,0,4
215,Apoptosis WP254,0.7445357467827448,0.7373583260680034,0.21751658695807083,['CYCS'],0.8134742418552212,0,0,1
216,Neural Crest Differentiation WP2064,0.7445357467827448,0.7373583260680034,0.21751658695807083,['WNT8A'],0.8134742418552212,0,0,1
217,T-cell receptor (TCR) signaling pathway WP69,0.7606464851858048,0.7031704781704782,0.19237799846542744,['MAP4K1'],0.823452158274541,0,0,1
218,Head and Neck Squamous Cell Carcinoma WP4674,0.7606464851858048,0.7031704781704782,0.19237799846542744,['CCND1'],0.823452158274541,0,0,1
219,Apoptosis Modulation and Signaling WP1772,0.7708202980685982,0.6820794675272287,0.177545291549942,['CYCS'],0.8306556636720966,0,0,1
220,Joubert Syndrome WP4656,0.7805630597453306,0.6622111241676459,0.16405601719230067,['TMEM17'],0.8359405465843989,0,0,1
221,Alzheimer's disease WP2059,0.7898929741030549,0.643462124095927,0.1517655728880086,['CYCS'],0.8359405465843989,0,0,1
222,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7898929741030549,0.643462124095927,0.1517655728880086,['MC4R'],0.8359405465843989,0,0,1
223,Retinoblastoma gene in cancer WP2446,0.7898929741030549,0.643462124095927,0.1517655728880086,['CCND1'],0.8359405465843989,0,0,1
224,B Cell Receptor Signaling Pathway WP23,0.8195417175159723,0.5854123354123354,0.11650289484051253,['MAP4K1'],0.8634457380971851,0,0,1
225,Ras signaling WP4223,0.8287364939682874,0.6244717901091247,0.11730892072271933,"['SHC4', 'SHC3']",0.8692525003400704,0,0,2
226,EGF/EGFR signaling pathway WP437,0.8343436859592693,0.6159413650939075,0.11155305934899007,"['MAP4K1', 'FOSB']",0.8712615481698566,0,0,2
227,22q11.2 copy number variation syndrome WP4657,0.8516156400519188,0.5245029512270891,0.08424565387209072,['CYP26A1'],0.8803135367442299,0,0,1
228,DNA damage response (only ATM dependent) WP710,0.8548083983749745,0.5185042997542998,0.08134188156633697,['CCND1'],0.8803135367442299,0,0,1
229,Hippo-Merlin Signaling Dysregulation WP4541,0.8548083983749745,0.5185042997542998,0.08134188156633697,['CCND1'],0.8803135367442299,0,0,1
230,ESC Pluripotency Pathways WP3931,0.8579326841151392,0.5126404494382022,0.07855171116535069,['FGF1'],0.8803135367442299,0,0,1
231,Thermogenesis WP4321,0.8669091864542641,0.49581374853113985,0.0708126412910755,['ADCY10'],0.8847700112621542,0,0,1
232,NRF2 pathway WP2884,0.869773909376355,0.49044609125254285,0.0684280074722559,['EGR1'],0.8847700112621542,0,0,1
233,Mesodermal commitment pathway WP2857,0.8975052335332974,0.43821465696465695,0.04738692361781208,['CCND1'],0.9090610949092626,0,0,1
234,Regulation of Actin Cytoskeleton WP51,0.9337167279952607,0.3669899738448126,0.025168970917387217,['FGF1'],0.941697212849921,0,0,1
235,Integrated breast cancer pathway WP1984,0.944331727098334,0.344543407043407,0.019734677589763747,['CCND1'],0.9483501599796035,0,0,1
236,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9927340601903395,0.20073573573573575,0.001463858390718088,['FGF1'],0.9927340601903395,0,0,1
